NCT00393276 - Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

HIV InfectionsHepatitis C

Interventions

BIOLOGICAL

Twinrix

Combined hepatitis A and hepatitis B immunization

BIOLOGICAL

Decavac

Diphtheria and tetanus toxoid vaccine

Trial Locations (12)

21201

IHV Baltimore Treatment CRS, Baltimore

27710

Duke Univ. Med. Ctr. Adult CRS, Durham

43210

The Ohio State University Medical Center, Columbus

44109

MetroHealth CRS, Cleveland

80045

University of Colorado Hospital CRS, Aurora

92103

UCSD Antiviral Research Center CRS, San Diego

94110

Ucsf Aids Crs, San Francisco

02114

Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS, Boston

10032-3732

Columbia P&S CRS, New York

44106-5083

Case CRS, Cleveland

Unknown

Trinity Health and Wellness Center CRS, Dallas

Puerto Rico AIDS Clinical Trials Unit CRS, San Juan

All Listed Sponsors

collaborator

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH